Hookipa Pharma (HOOK) Short Interest Ratio & Short Volume → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free HOOK Stock Alerts $0.80 -0.03 (-3.61%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Hookipa Pharma Short Interest DataCurrent Short Volume316,700 sharesPrevious Short Volume315,900 sharesChange Vs. Previous Month+0.25%Dollar Volume Sold Short$240,692.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 15, 2024Outstanding Shares98,950,000 sharesFloat Size70,400,000 sharesShort Percent of Float0.45%Today's Trading Volume523,931 sharesAverage Trading Volume740,845 sharesToday's Volume Vs. Average71% Short Selling Hookipa Pharma ? Sign up to receive the latest short interest report for Hookipa Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHOOK Short Interest Over TimeHOOK Days to Cover Over TimeHOOK Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Hookipa Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024316,700 shares $240,692.00 +0.3%0.5%0.5 $0.76 3/31/2024315,900 shares $224,920.80 -5.3%0.5%0.6 $0.71 3/15/2024333,400 shares $239,714.60 +11.3%0.6%0.1 $0.72 2/29/2024299,500 shares $230,016.00 -10.0%0.5%0.1 $0.77 2/15/2024332,600 shares $219,516.00 -25.4%0.6%0.1 $0.66 1/31/2024446,100 shares $277,072.71 -28.1%0.8%0.2 $0.62 Get the Latest News and Ratings for HOOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024620,200 shares $474,390.98 -21.0%1.0%0.3 $0.76 12/31/2023785,400 shares $636,174.00 +142.9%1.3%0.3 $0.81 12/15/2023323,300 shares $211,114.90 -29.6%0.4%0.1 $0.65 11/30/2023459,000 shares $261,171.00 +99.5%0.6%1 $0.57 11/15/2023230,100 shares $109,297.50 -26.7%0.3%0.5 $0.48 10/31/2023313,900 shares $135,604.80 -10.5%0.4%0.9 $0.43 10/15/2023350,800 shares $191,536.80 -12.1%0.5%0.9 $0.55 9/30/2023399,000 shares $245,784.00 +68.9%0.5%1 $0.62 9/15/2023236,200 shares $165,340.00 +5.2%0.3%0.5 $0.70 8/31/2023224,600 shares $147,113.00 -20.5%0.3%0.3 $0.66 8/15/2023282,400 shares $206,152.00 -2.0%0.4%0.3 $0.73 7/31/2023288,200 shares $227,678.00 -64.2%0.4%0.2 $0.79 7/15/2023805,900 shares $710,964.98 -11.5%1.2%0.5 $0.88 6/30/2023910,600 shares $801,328.00 +26.3%1.4%0.6 $0.88 6/15/2023721,000 shares $771,470.00 +951.0%1.1%0.5 $1.07 5/31/202368,600 shares $89,866.00 -78.2%0.1%0.1 $1.31 5/15/2023314,900 shares $585,714.00 No Change0.7%0.4 $1.86 10/31/2022879,900 shares $1.14 million -4.3%N/A0.9 $1.29 10/15/2022919,600 shares $1.09 million -9.8%N/A1 $1.19 9/30/20221,020,000 shares $1.37 million +2.0%N/A4.9 $1.34 9/15/20221,000,000 shares $1.41 million -3.9%N/A3.7 $1.41 8/31/20221,040,000 shares $1.55 million -17.5%N/A3.2 $1.49 8/15/20221,260,000 shares $2.17 million -46.2%N/A3.1 $1.73 7/31/20222,340,000 shares $3.21 million -2.5%N/A5.3 $1.37 7/15/20222,400,000 shares $3.96 million -29.6%N/A5.4 $1.65 6/30/20223,410,000 shares $5.56 million -14.1%N/A5.6 $1.63 6/15/20223,970,000 shares $6.67 million -3.6%N/A4.6 $1.68 5/31/20224,120,000 shares $7.09 million -0.7%N/A4.2 $1.72 5/15/20224,150,000 shares $5.69 million +2.7%N/A1.2 $1.37 4/30/20224,040,000 shares $6.06 million +5.2%N/A0.6 $1.50 4/15/20223,840,000 shares $6.87 million -2.5%N/A0.6 $1.79 3/31/20223,940,000 shares $8.98 million +1.8%N/A0.6 $2.28 3/15/20223,870,000 shares $5.84 million -16.8%N/A0.6 $1.51 2/28/20224,650,000 shares $11.16 million +63.7%27.7%0.8 $2.40Could this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. HOOK Short Interest - Frequently Asked Questions What is Hookipa Pharma's current short interest? Short interest is the volume of Hookipa Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 316,700 shares of HOOK short. 0.45% of Hookipa Pharma's shares are currently sold short. Learn More on Hookipa Pharma's current short interest. What is a good short interest percentage for Hookipa Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.45% of Hookipa Pharma's floating shares are currently sold short. Is Hookipa Pharma's short interest increasing or decreasing? Hookipa Pharma saw a increase in short interest in April. As of April 15th, there was short interest totaling 316,700 shares, an increase of 0.3% from the previous total of 315,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hookipa Pharma's float size? Hookipa Pharma currently has issued a total of 98,950,000 shares. Some of Hookipa Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hookipa Pharma currently has a public float of 70,400,000 shares. How does Hookipa Pharma's short interest compare to its competitors? 0.45% of Hookipa Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Hookipa Pharma: Jaguar Health, Inc. (5.20%), Corvus Pharmaceuticals, Inc. (3.71%), LifeVantage Co. (0.66%), Tempest Therapeutics, Inc. (6.74%), Connect Biopharma Holdings Limited (0.16%), Affimed (1.66%), Leap Therapeutics, Inc. (6.19%), Reviva Pharmaceuticals Holdings, Inc. (4.41%), Anebulo Pharmaceuticals, Inc. (0.22%), Marinus Pharmaceuticals, Inc. (8.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Hookipa Pharma stock? Short selling HOOK is an investing strategy that aims to generate trading profit from Hookipa Pharma as its price is falling. HOOK shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hookipa Pharma? A short squeeze for Hookipa Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HOOK, which in turn drives the price of the stock up even further. How often is Hookipa Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOOK, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: JAGX Short Interest CRVS Short Interest LFVN Short Interest TPST Short Interest CNTB Short Interest AFMD Short Interest LPTX Short Interest RVPH Short Interest ANEB Short Interest MRNS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HOOK) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings